Poor inhaler technique has been a major problem in managing respiratory illness for decades [1]; in fact, since the introduction of the first inhaler, the pressurised metered dose inhaler (pMDI) in the 1950’s, it is it has been recognised as a problem. Unfortunately, poor inhaler technique remains a problem today with up to 90% of patients failing to use their inhaler correctly. This compromises disease control [2] and is associated with an increase in the economic burden of disease management [3]. Incorrect inhaler use remains common in clinical practice [4] and its co-existence with poor asthma control cannot be ignored [5].
This program of research takes a multifaceted and multidisciplinary approach to generating new knowledge around inhaler use. It focuses on answer the following questions:
Program Type: Honours, Masters of Philosophy, Doctor of Philosophy programs.
Research Group: Quality Use of Respiratory Medicines Group
Supervisors: Professor Sinthia Bosnic-Anticevich and the Quality Use of Respiratory Medicines Group in collaboration with international collaborators will supervise the candidate.
Synopsis and Research Plan: This research involves a range of research techniques including qualitative (interviews) and quantitative methodologies (both cross-sectional and/or longitudinal, observational and/or interventional). The scope of the research plan is dependent on the category of candidature.
Significance: This research involves a range of research techniques including qualitative (interviews) and quantitative methodologies (both cross-sectional and/or longitudinal, observational and/or interventional). The scope of the research plan is dependent on the category of candidature.
Funding: Currently, there is some funding for specific aspects of this program of research.
Candidate: A healthcare professional background is favourable but not essential.
Contact: Professor Sinthia Bosnic-Anticevich, Sinthia.bosnic-anticevich@sydney.edu.au, 02 9114 0145 or 0414 015 614.